Refresh

Zenith Drugs Ltd. - Research Center

Group () BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 23

Sales

69.41

Operating profit

11.09

Interest

1.46

Gross profit

9.71

EPS (Rs)

142.53
Half yearly  results in details
Sep ' 23

Other income

0.08

Stock adjustment

1.40

Raw material

40.22

Power and fuel

-

Employee expenses

3.29

Excise

-

Admin and selling expenses

-

Research and development expenses

-

Expenses capitalised

-

Other expenses

13.41

Provisions made

-

Depreciation

0.63

Taxation

1.93

Net profit / loss

5.70

Extra ordinary item

-1.44

Prior year adjustments

-

Equity capital

0.40

Equity dividend rate

-

Agg.of non-prom. shares (Lacs)

-

Agg.of non promotoholding (%)

-

OPM (%)

15.98

GPM (%)

13.97

NPM (%)

8.20
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com